OTC · Healthcare

STRATA Skin Sciences, Inc. (SSKN)

As-reported financials and recent SEC filings for STRATA Skin Sciences, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$30.7M

Net income

$-6.3M

Net margin

-20.4%

Diluted EPS

$-1.35

ROE

-215.3%

P/E (TTM)

—

Market cap

—

Debt / equity

0.0×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$30.7M	$33.6M	$33.4M	$36.2M	$30.0M
Gross profit	$17.9M	$19.2M	$18.5M	$21.8M	$19.9M
Operating income	$-4.7M	$-9.3M	$-8.6M	$-4.6M	$-4.4M
Net income	$-6.3M	$-10.1M	$-10.8M	$-5.5M	$-2.7M
Diluted EPS	$-1.35	$-2.65	$-3.10	$-1.60	—

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

10-K2026-03-26

EFFECT2026-03-04

EFFECT2026-03-04

EFFECT2026-03-04

15-12G2026-03-02

POS AM2026-02-27

POS AM2026-02-27

POS AM2026-02-27

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on SSKN

Search STRATA Skin Sciences, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.